Clinical Trials Directory

Trials / Unknown

UnknownNCT04164056

Hippocampal and Thalamic DBS for Bilateral Temporal Lobe Epilepsy

Hippocampal and Thalamic Deep Brain Stimulation for Bilateral Temporal Lobe Epilepsy

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
Sex
All
Age
12 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The study aims to compare the safety and effectiveness of deep brain stimulation of the hippocampus and the anterior nucleus of the thalamus for reducing the frequency of seizures in patients with bilateral temporal lobe epilepsy.

Detailed description

The outcome of resective surgery for bilateral temporal lobe epilepsy (BTLE) is poor. Neuromodulation such as deep brain stimulation is an alternative therapy for patients with drug-resistant epilepsy, especially for those not suitable for resective surgery. This prospective, randomized, open-label trial aims to compare the effectiveness of deep brain stimulation of the hippocampus and the anterior nucleus of the thalamus for bilateral temporal lobe epilepsy.

Conditions

Interventions

TypeNameDescription
DEVICEdeep brain stimulationdeep brain stimulation on the hippocampus or the anterior nucleus of the thalamus

Timeline

Start date
2019-11-01
Primary completion
2022-09-01
Completion
2024-09-01
First posted
2019-11-15
Last updated
2019-11-15

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04164056. Inclusion in this directory is not an endorsement.

Hippocampal and Thalamic DBS for Bilateral Temporal Lobe Epilepsy (NCT04164056) · Clinical Trials Directory